Abstract | OBJECTIVES: METHOD AND MATERIALS: This was a double-blind randomized controlled pilot trial of consecutive patients requiring surgical removal of mandibular third molars. Immediately post extraction, the surgeon administered a submucosal injection. The surgeon was masked to the content of the injection, which contained either a mixture of 10 mg dexamethasone and 68 mg articaine ("study group") or the same volume of saline only ("control group"). Pain severity was assessed by questionnaire (postoperative symptom severity [PoSSe] scale) 7 days after the procedure. RESULTS: Sixty subjects were enrolled. Patients in the study group had significantly lower PoSSe pain intensity scores than subjects in the control group (P = .004). The combined postoperative PoSSe pain score was significantly lower in the study group than in the control group (P = .016). There was no significant difference in pain duration between the two groups (P = .237). CONCLUSION:
|
Authors | Murad Abdelraziq, Michael V Joachim, Cory M Resnick, Ephraim Winocur, Amir Laviv, Imad Abu El-Naaj |
Journal | Quintessence international (Berlin, Germany : 1985)
(Quintessence Int)
Vol. 54
Issue 1
Pg. 24-32
(Jan 13 2023)
ISSN: 1936-7163 [Electronic] Germany |
PMID | 36268946
(Publication Type: Randomized Controlled Trial, Journal Article)
|
Chemical References |
|
Topics |
- Humans
- Dexamethasone
- Carticaine
- Molar, Third
(surgery)
- Tooth, Impacted
(surgery)
- Pain, Postoperative
(drug therapy, prevention & control)
- Tooth Extraction
(methods)
- Double-Blind Method
|